BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721
1443 results:

  • 1. Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/Akt signaling pathway.
    Yao N; Ma Q; Yi W; Zhu Y; Liu Y; Gao X; Zhang Q; Luo W
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):202. PubMed ID: 38630320
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort.
    Ichimura N; Urata Y; Kobayashi T; Hibi H
    Oral Oncol; 2024 May; 152():106807. PubMed ID: 38615585
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deciphering the role of wound healing genes in skin cutaneous melanoma: Insights into expression, methylation, mutations, and therapeutic implications.
    Zhang Y; Gao C; Luo J; Khan A; Salem-Bekhit MM; Salem MM; Qi Z; Jiang B
    Int Wound J; 2024 Apr; 21(4):e14807. PubMed ID: 38591163
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of CREB5 as a prognostic and immunotherapeutic biomarker in glioma through multi-omics pan-cancer analysis.
    Wu Z; Wang X; Wu H; Du S; Wang Z; Xie S; Zhang R; Chen G; Chen H
    Comput Biol Med; 2024 May; 173():108307. PubMed ID: 38547657
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
    Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. IL-12-Overexpressed Nanoparticles Suppress the Proliferation of Melanoma Through Inducing ICD and Activating DC, CD8
    Shen HH; Peng JF; Wang RR; Wang PY; Zhang JX; Sun HF; Liang Y; Li YM; Xue JN; Li YJ; Sun GB; Xie SY
    Int J Nanomedicine; 2024; 19():2755-2772. PubMed ID: 38525008
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [MACULOPAPULAR CUTANEOUS MASTOCYTOSIS HARBORING A kit MUTATION (ASP419DEL): A CASE REPORT].
    Fukaura A; Numata T; Chiyotanda M; Maeda T; Egusa C; Ito T; Harada K; Okubo Y
    Arerugi; 2024; 73(2):189-195. PubMed ID: 38522933
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of immunological patterns characterizing immune-related psoriasis reactions in oncological patients in therapy with anti-PD-1 checkpoint inhibitors.
    Morelli M; Carbone ML; Scaglione GL; Scarponi C; Di Francesco V; Pallotta S; De Galitiis F; Rahimi S; Madonna S; Failla CM; Albanesi C
    Front Immunol; 2024; 15():1346687. PubMed ID: 38495872
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances.
    Kim HJ; Kim YH
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474231
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Study on the mechanism of S100A4-mediated cancer oncogenesis in uveal melanoma cells through the integration of bioinformatics and in vitro experiments.
    Chen H; Zhang W; Shi J; Tang Y; Chen X; Li J; Yao X
    Gene; 2024 Jun; 911():148333. PubMed ID: 38431233
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of the anti-aging effects of Zinc-α2-glycoprotein peptide in clinical and in vitro study.
    Lee SG; Ham S; Lee J; Jang Y; Suk J; Lee YI; Lee JH
    Skin Res Technol; 2024 Mar; 30(3):e13609. PubMed ID: 38419415
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nilotinib in kit-driven advanced melanoma: Results from the phase II single-arm NICAM trial.
    Larkin J; Marais R; Porta N; Gonzalez de Castro D; Parsons L; Messiou C; Stamp G; Thompson L; Edmonds K; Sarker S; Banerji J; Lorigan P; Evans TRJ; Corrie P; Marshall E; Middleton MR; Nathan P; Nicholson S; Ottensmeier C; Plummer R; Bliss J; Valpione S; Turajlic S
    Cell Rep Med; 2024 Mar; 5(3):101435. PubMed ID: 38417447
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cross-Species Comparison of the Pan-RAF Inhibitor LY3009120's Anti-Tumor Effects in Equine, Canine, and Human Malignant Melanoma Cell Lines.
    Gao Y; Packeiser EM; Wendt S; Sekora A; Cavalleri JV; Pratscher B; Alammar M; Hühns M; Brenig B; Junghanss C; Nolte I; Murua Escobar H
    Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397192
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. ALDH2 is a novel biomarker and exerts an inhibitory effect on melanoma.
    Lei H; Liao J; Wang X; Huang R; Ying C; Yang J
    Sci Rep; 2024 Feb; 14(1):4183. PubMed ID: 38378847
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
    Bai X; Li S; Luo Y
    Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Conjunctival leiomyosarcoma: A clinico-pathological study with in deep molecular characterization.
    Santoro A; Angelico G; Mulè A; Minucci A; Giannuzzi F; Sammarco MG; Pagliara MM; Blasi MA
    Pathol Res Pract; 2024 Mar; 255():155182. PubMed ID: 38335782
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Water-soluble intracellular extract of Desmodesmus sp. YT enhanced the antioxidant capacity of human skin fibroblast to protect the skin from UV damage.
    Ying M; Zeng Z; Li Q; Chen X; Xiong Y; Wu B; Peng L; Zhang Q; Wang L; Dai Z; Li S; Chen H; Yang X
    J Cosmet Dermatol; 2024 May; 23(5):1850-1861. PubMed ID: 38327116
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evodiamine inhibits growth of vemurafenib drug-resistant melanoma via suppressing IRS4/PI3K/AKT signaling pathway.
    Guo X; Huang S; Zhang Y; Wang H; Li L; Ran J; Chen D; Li X; Li J
    J Nat Med; 2024 Mar; 78(2):342-354. PubMed ID: 38324123
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The promotive role of lncRNA MIR205HG in proliferation, invasion, and migration of melanoma cells via the JMJD2C/ALKBH5 axis.
    Liu Y; Wang S; Wei S; Qiu X; Mei Y; Yan L
    PLoS One; 2024; 19(1):e0290986. PubMed ID: 38252669
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mastocytosis in the skin in dogs: A multicentric case series.
    Wyatt EK; Affolter V; Borio S; Guillen A; Verganti S; Murphy S; Ballarini D; Banovic F; Schmidt V; Tanis JB
    Vet Comp Oncol; 2024 Mar; 22(1):136-148. PubMed ID: 38243867
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 73.